Skip to content

ultrasound-guided stellate ganglion block for myocardial injury after video-assisted thoracoscopic surgery: a randomized controlled trial

ultrasound-guided stellate ganglion block for myocardial injury after video-assisted thoracoscopic surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071469
Enrollment
Unknown
Registered
2023-05-16
Start date
2023-06-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial injury

Interventions

Sponsors

Shanghai Pulmonary Hospital, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age 45 or above; 2. Patients undergoing video-assisted thoracoscopic lung surgery under general anesthesia; 3. The operation is expected to last more than an hour; 4. Comply with any of the following 4 items: (1) History of coronary heart disease, including angina pectoris; (2) A history of stroke; (3) History of peripheral arterial disease; (4) Any 2 of the following 8 items: 1) Emergency surgery; 2) Current or former daily smoker; 3) High blood pressure; 4) diabetes that needs treatment; 5) History of cerebral ischemia; 6) Plasma creatinine >175µM; 7) Age 70 or above; 8) History of congestive heart failure.

Exclusion criteria

Exclusion criteria: 1. Coagulation dysfunction; 2. Local skin infection; 3. Glaucoma; 4. Thyroid disease; 5. Cardiac excitation conduction abnormalities; 6. The patient is mentally disabled and unable to cooperate; 7. Pregnant woman; 8. Did not sign informed consent before surgery, or refused to participate; 9. Allergy to the drug involved in the trial; 10. Sepsis; 11. Preoperative positive inotropic drug therapy was received; 12. Severe heart failure (defined as ejection fraction <30%).

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative myocardial injury;

Secondary

MeasureTime frame
Postoperative myocardial markers;Mortality at 30 and 60 days after surgery;Incidence of acute kidney injury;Delirium incidence;Incidence of myocardial infarction;Major adverse cardiac events (MACE) and postoperative complications;Length of stay and readmission rate;Postoperative Recovery Quality Scale;

Countries

China

Contacts

Public ContactHong Shi

Shanghai Pulmonary Hospital, Tongji University

13651958255@139.com+86 136 5195 8255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026